{
    "code": "06016838",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06016838",
    "time": "2021-03-12 05:10:47",
    "許可證字號": "衛署醫器輸字第016838號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD1027",
    "有效日期": "115\/06\/09",
    "發證日期": "95\/06\/09",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00601683801",
    "中文品名": "立可測 尿液毒物品管液(濃度C1,C2, C3,C4, C2鴉片劑, C3,鴉片劑)",
    "英文品名": "Liquichek Urine Toxicology Control (C1, C2, C3, C4, C2 Low Opiate, C3 Low Opiate)",
    "效能": "用以監控實驗室執行尿液毒物確認步驟的品管物質。",
    "醫器規格": "#441、#442、#443、#444、#468及469。\r\n新增規格：#441X、#442X、#443X、#444X、#468X及#469X。標籤、仿單變更為：詳如中文仿單核定本（原95年8月2日仿單標籤核定本正本收回作廢）。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A1660品管材料(分析與非分析)",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "0939801100  美商伯瑞股份有限公司台灣分公司",
    "申請商地址": "台北市松山區南京東路4段126號14樓",
    "主製造廠": [
        {
            "製造廠名稱": "MUS1707000  BIO-RAD LABORATORIES",
            "製造廠廠址": "9500 JERONIMO ROAD, IRVINE, CA 92618, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "20181122102836602-107-11-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06016838&Seq=002&Type=9"
        },
        {
            "title": "20181122102836602-107-11-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06016838&Seq=002&Type=8"
        }
    ]
}